REVIEW
LUO Meng, CHEN Jiaqi, YANG Zhilun, ZHONG Xiaoru
The management of medical consumables is a key task in deepening the reform of the medical and health system, and the governance of high-value medical consumables in particular is crucial for standardizing the medical market and safeguarding patients’ rights and interests. Currently, research on the full-life-cycle management of medical consumables has expanded from single-institution logistics management to a multi-dimensional approach, yet significant gaps remain. Specifically, it is difficult to align the intentions of stakeholders, and the interest conflicts among the four parties-government, medical institutions, enterprises, and patients-in areas such as policy implementation, cost control, and quality assurance have not been systematically resolved. This leads to prominent issues including an unclear market operation mechanism and information asymmetry, which hinder the rational allocation of medical resources. Against this backdrop, this paper, from the perspective of stakeholders, identified the four core stakeholder groups, sorted out their research status and interest demands across all stages of the medical consumables’ full life cycle including R&D, production, circulation, usage, and supervision & evaluation, and analyzed the points of interest conflict. Finally, targeted optimization suggestions were proposed, aiming to provide a scientific basis for the formulation of relevant policies, thereby promoting the fair and stable operation of the medical market, reducing interest conflicts, protecting patients’ rights and interests, and advancing the healthy and sustainable development of the medical industry.